Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-04 4:22 pm Purchase | 2025-10-29 | 13G | OrthoPediatrics Corp. KIDS | Integrated Core Strategies (US) LLC | 1,390,656 5.500% | 1,390,656 (New Position) | Filing History |
| 2025-10-30 4:19 pm Sale | 2025-09-30 | 13G | Cumberland Pharmaceuticals Inc. CPIX | Integrated Core Strategies (US) LLC | 598,634 4.000% | -211,263 (-26.09%) | Filing History |
| 2025-10-30 4:19 pm Sale | 2025-09-30 | 13G | Affiliated Managers Group, Inc. AMG | Integrated Core Strategies (US) LLC | 1,017,113 3.600% | -488,991 (-32.47%) | Filing History |
| 2025-10-29 4:07 pm Purchase | 2025-10-23 | 13G | HARVARD INDUSTRIES INC HAVA | Integrated Core Strategies (US) LLC | 950,000 6.400% | 950,000 (New Position) | Filing History |
| 2025-10-28 4:10 pm Sale | 2025-09-30 | 13G | Nektar Therapeutics NKTR | Integrated Core Strategies (US) LLC | 570,994 3.000% | -361,869 (-38.79%) | Filing History |
| 2025-10-27 4:32 pm Purchase | 2025-10-20 | 13G | Quoin Pharmaceuticals, Ltd. QNRX | Integrated Core Strategies (US) LLC | 1,901,585 9.000% | 1,901,585 (New Position) | Filing History |
| 2025-10-23 4:18 pm Purchase | 2025-10-16 | 13G | First Horizon Corporation FHN | Integrated Core Strategies (US) LLC | 25,405,699 5.000% | 25,405,699 (New Position) | Filing History |
| 2025-10-20 4:23 pm Sale | 2025-10-14 | 13G | Astria Therapeutics, Inc. ATXS | Integrated Core Strategies (US) LLC | 222,101 0.400% | -2,715,702 (-92.44%) | Filing History |
| 2025-10-09 4:06 pm Sale | 2025-10-07 | 13G | Comerica Incorporated CMA | Integrated Core Strategies (US) LLC | 4,608,328 3.600% | -4,074,815 (-46.93%) | Filing History |
| 2025-10-01 4:15 pm Purchase | 2025-09-29 | 13G | BioXcel Therapeutics, Inc. BTAI | Integrated Core Strategies (US) LLC | 1,028,053 5.200% | 1,028,053 (New Position) | Filing History |
| 2025-09-26 4:23 pm Purchase | 2025-09-24 | 13G | Cryoport, Inc. CYRX | Integrated Core Strategies (US) LLC | 2,562,717 5.100% | 350,146 (+15.83%) | Filing History |
| 2025-08-07 4:18 pm Purchase | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Integrated Core Strategies (US) LLC | 2,836,292 5.300% | 902,913 (+46.70%) | Filing History |
| 2025-08-05 4:26 pm Sale | 2025-06-30 | 13G | Cryoport, Inc. CYRX | Integrated Core Strategies (US) LLC | 2,212,571 4.400% | -1,517,945 (-40.69%) | Filing History |
| 2025-08-04 4:05 pm Purchase | 2025-06-30 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,924,714 5.300% | 380,564 (+8.37%) | Filing History |
| 2025-08-01 4:32 pm Sale | 2025-06-30 | 13G | UWM Holdings Corporation UWMC | Integrated Core Strategies (US) LLC | 4,974,748 2.500% | -7,671,408 (-60.66%) | Filing History |
| 2025-07-30 4:15 pm Sale | 2025-06-30 | 13G | Helix Acquisition Corp. II HLXB | Integrated Core Strategies (US) LLC | 897,251 4.700% | -202,749 (-18.43%) | Filing History |
| 2025-07-23 4:15 pm Purchase | 2025-07-16 | 13G | Comerica Incorporated CMA | Integrated Core Strategies (US) LLC | 8,683,143 6.600% | 8,683,143 (New Position) | Filing History |
| 2025-07-22 4:11 pm Purchase | 2025-07-16 | 13G | AngioDynamics, Inc. ANGO | Integrated Core Strategies (US) LLC | 2,145,888 5.300% | 2,145,888 (New Position) | Filing History |
| 2025-07-17 4:31 pm Sale | 2025-06-30 | 13G | NeoGenomics, Inc. NEO | Integrated Core Strategies (US) LLC | 3,566,808 2.800% | -3,387,312 (-48.71%) | Filing History |
| 2025-07-03 2:07 pm Purchase | 2025-06-27 | 13G | Nektar Therapeutics NKTR | Integrated Core Strategies (US) LLC | 932,863 5.400% | 932,863 (New Position) | Filing History |